82 [exclusive] | Pda Technical Report

: Recommends using Reference Standard Endotoxin (RSE) or Control Standard Endotoxin (CSE) as the primary analytes for hold-time studies to ensure reproducibility.

What (FDA, EMA, etc.) are you preparing documentation for?

, is a critical resource for pharmaceutical professionals navigating the complex landscape of endotoxin testing in biologics.

PDA TR 82 emphasizes that LER hold-time studies are but rather a mandatory supplementary investigation. The report recommends the following approach: pda technical report 82

In certain pharmaceutical formulations—particularly those containing buffers, chelating agents (like citrate or phosphate), and surfactants (like Polysorbate 80)—known amounts of endotoxin added (spiked) to a product cannot be recovered using traditional LAL methods after holding for a period.

Introducing specific modulators, bovine serum albumin (BSA), or localized dispersing agents to disrupt surfactant binding.

Integrating LER assessments into an overarching Quality Risk Management (QRM) framework. Designing Regulatory-Compliant Hold-Time Studies : Recommends using Reference Standard Endotoxin (RSE) or

Studies must simulate real-world manufacturing and storage conditions. This typically includes testing at multiple temperature intervals (e.g., 2–8°C and 20–25°C) over extended periods, matching or exceeding the maximum hold times permitted during routine production. 3. Acceptance Criteria

This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.

: Provides a standardized protocol for conducting LER hold-time studies , detailing endotoxin sources, spiking methods, and storage conditions. PDA TR 82 emphasizes that LER hold-time studies

Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens that can cause severe fever, shock, and death if introduced into the human bloodstream. Traditionally, the Limulus Amebocyte Lysate (LAL) test has been the gold standard for detecting these contaminants.

: Once the structural aggregate is weakened by the chelator, the surfactant breaks down the larger micelles into individual LPS monomers. The surfactant then coats these monomers, hiding the Lipid A core responsible for triggering the LAL clotting cascade.